Jerrold B Grossman has bought ADMA on 9 days since May 2016

Jerrold B. Grossman is a director of ADMA Biologics, Inc. (NASDAQ: ADMA) and a long‑standing corporate insider with substantial direct and indirect equity ownership in the company.( As a board member, he participates in the oversight of ADMA’s strategic, financial, and operational direction, and his ongoing open‑market share purchases underscore an active, long‑term alignment with shareholder interests.( Recent Form 4 filings report that he has repeatedly increased his stake through open‑market transactions, including purchases of 12,500 shares on May 12, 2026 and 6,400 shares on May 27, 2026, bringing his direct holdings (common stock plus restricted stock units) to more than 520,000 shares, in addition to indirect holdings through an LLC, an irrevocable trust, a charitable foundation, and shares held by his spouse.(

Beyond his role as a director, Grossman is associated with Genesis Foundation Inc. and the Jerrold Grossman 2019 Irrevocable Trust, which hold ADMA shares, and with Brookwood LLC, another vehicle reported as an indirect owner, reflecting his use of multiple entities for investment and estate‑planning purposes.( A Schedule 14A proxy statement for ADMA identifies Genesis as owned by Jerrold and Adam Grossman, further evidencing his broader leadership and philanthropic footprint connected to the company’s shareholder base.( Public filings primarily highlight his governance role and investment activity at ADMA; specific details of his earlier career positions or formal education are not disclosed in the cited documents and remain outside currently available regulatory and financial reporting sources.(

Written by Perplexity from public sources.